Crossmark

A novel machine learning-based immune prognostic signature for improving clinical outcomes and guiding therapy in colorectal cancer: an integrated bioinformatics and experimental study

Crossref DOI link: https://doi.org/10.1186/s12885-025-13437-0

Published Online: 2025-01-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Yuanchun

Xun, Dexu

Chen, Jiajia

Qi, Xin
Funding

Funding for this research was provided by:

Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX23_3344)

National Natural Science Foundation of China (32270705)
License Information

Text and Data Mining valid from 2025-01-10

Version of Record valid from 2025-01-10
More Information

Article History

Received: 29 August 2024

Accepted: 2 January 2025

First Online: 10 January 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below